Independent modes of transcriptional activation by the p50 and p65 subunits of NF-κB
Abstract
Recombinant subunits of the transcription factor NF-κB, p50 and p65, were analyzed both for binding to various κB motifs and in vitro activation. The subunits preferentially form a heterodimer that activates transcription. Although p50 and p65 bind DNA individually as homodimers and are structurally related, their activation mechanisms are distinct. p65 activates transcription by its unique carboxy-terminal activation domain. (p50)₂ displays higher affinity DNA binding than (p65)₂ for many distinct κB motifs and provides strong transcriptional activation only when adopting a chymotrypsin-resistant conformation induced by certain κB motifs but not others. Thus, (p50)₂ acts as a positive regulator in vitro, consistent with its isolation as a putative constitutive regulator of MHC class I genes. Both subunits of NF-κB, therefore, contribute independently to provide regulation at given κB motifs.
Additional Information
© 1992 Cold Spring Harbor Laboratory Press. Received November 13, 1991; revised version accepted March 6, 1992. We thank M. Horikoshi and H. Harada for advice and help for Scatchard analysis, respectively. T.F. was supported by a fellowship from Human Frontier Science Program; G.P.N, was supported by a fellowship from National Institutes of Health (NM); S.G. was supported by a fellowship from the Irvington Institute for Medical Research. This work was supported by NIH grant GM39458-04 to D.B. The publication costs of this article were defrayed m part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.Attached Files
Published - Genes_Dev.-1992-Fujita-775-87.pdf
Files
Name | Size | Download all |
---|---|---|
md5:2010232f3dbb2a9e2736db75aa81a52e
|
2.1 MB | Preview Download |
Additional details
- Eprint ID
- 103216
- Resolver ID
- CaltechAUTHORS:20200514-154625749
- Human Frontier Science Program
- NIH
- GM39458-04
- Irvington Institute for Medical Research
- Created
-
2020-05-14Created from EPrint's datestamp field
- Updated
-
2021-11-16Created from EPrint's last_modified field